Global RNA-based Biopharmaceuticals Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global RNA-based Biopharmaceuticals Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for RNA-based Biopharmaceuticals by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for RNA-based Biopharmaceuticals by Country/Region, 2017, 2022 & 2028

2.2 RNA-based Biopharmaceuticals Segment by Type

2.2.1 Therapeutics

2.2.2 Vaccines

2.3 RNA-based Biopharmaceuticals Sales by Type

2.3.1 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2017-2022)

2.3.2 Global RNA-based Biopharmaceuticals Revenue and Market Share by Type (2017-2022)

2.3.3 Global RNA-based Biopharmaceuticals Sale Price by Type (2017-2022)

2.4 RNA-based Biopharmaceuticals Segment by Application

2.4.1 Cancer

2.4.2 Diabetes

2.4.3 Tuberculosis

2.4.4 Cardiovascular Diseases

2.4.5 Others

2.5 RNA-based Biopharmaceuticals Sales by Application

2.5.1 Global RNA-based Biopharmaceuticals Sale Market Share by Application (2017-2022)

2.5.2 Global RNA-based Biopharmaceuticals Revenue and Market Share by Application (2017-2022)

2.5.3 Global RNA-based Biopharmaceuticals Sale Price by Application (2017-2022)

3 Global RNA-based Biopharmaceuticals by Company

3.1 Global RNA-based Biopharmaceuticals Breakdown Data by Company

3.1.1 Global RNA-based Biopharmaceuticals Annual Sales by Company (2020-2022)

3.1.2 Global RNA-based Biopharmaceuticals Sales Market Share by Company (2020-2022)

3.2 Global RNA-based Biopharmaceuticals Annual Revenue by Company (2020-2022)

3.2.1 Global RNA-based Biopharmaceuticals Revenue by Company (2020-2022)

3.2.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Company (2020-2022)

3.3 Global RNA-based Biopharmaceuticals Sale Price by Company

3.4 Key Manufacturers RNA-based Biopharmaceuticals Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers RNA-based Biopharmaceuticals Product Location Distribution

3.4.2 Players RNA-based Biopharmaceuticals Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for RNA-based Biopharmaceuticals by Geographic Region

4.1 World Historic RNA-based Biopharmaceuticals Market Size by Geographic Region (2017-2022)

4.1.1 Global RNA-based Biopharmaceuticals Annual Sales by Geographic Region (2017-2022)

4.1.2 Global RNA-based Biopharmaceuticals Annual Revenue by Geographic Region

4.2 World Historic RNA-based Biopharmaceuticals Market Size by Country/Region (2017-2022)

4.2.1 Global RNA-based Biopharmaceuticals Annual Sales by Country/Region (2017-2022)

4.2.2 Global RNA-based Biopharmaceuticals Annual Revenue by Country/Region

4.3 Americas RNA-based Biopharmaceuticals Sales Growth

4.4 APAC RNA-based Biopharmaceuticals Sales Growth

4.5 Europe RNA-based Biopharmaceuticals Sales Growth

4.6 Middle East & Africa RNA-based Biopharmaceuticals Sales Growth

5 Americas

5.1 Americas RNA-based Biopharmaceuticals Sales by Country

5.1.1 Americas RNA-based Biopharmaceuticals Sales by Country (2017-2022)

5.1.2 Americas RNA-based Biopharmaceuticals Revenue by Country (2017-2022)

5.2 Americas RNA-based Biopharmaceuticals Sales by Type

5.3 Americas RNA-based Biopharmaceuticals Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC RNA-based Biopharmaceuticals Sales by Region

6.1.1 APAC RNA-based Biopharmaceuticals Sales by Region (2017-2022)

6.1.2 APAC RNA-based Biopharmaceuticals Revenue by Region (2017-2022)

6.2 APAC RNA-based Biopharmaceuticals Sales by Type

6.3 APAC RNA-based Biopharmaceuticals Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe RNA-based Biopharmaceuticals by Country

7.1.1 Europe RNA-based Biopharmaceuticals Sales by Country (2017-2022)

7.1.2 Europe RNA-based Biopharmaceuticals Revenue by Country (2017-2022)

7.2 Europe RNA-based Biopharmaceuticals Sales by Type

7.3 Europe RNA-based Biopharmaceuticals Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa RNA-based Biopharmaceuticals by Country

8.1.1 Middle East & Africa RNA-based Biopharmaceuticals Sales by Country (2017-2022)

8.1.2 Middle East & Africa RNA-based Biopharmaceuticals Revenue by Country (2017-2022)

8.2 Middle East & Africa RNA-based Biopharmaceuticals Sales by Type

8.3 Middle East & Africa RNA-based Biopharmaceuticals Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of RNA-based Biopharmaceuticals

10.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals

10.4 Industry Chain Structure of RNA-based Biopharmaceuticals

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 RNA-based Biopharmaceuticals Distributors

11.3 RNA-based Biopharmaceuticals Customer

12 World Forecast Review for RNA-based Biopharmaceuticals by Geographic Region

12.1 Global RNA-based Biopharmaceuticals Market Size Forecast by Region

12.1.1 Global RNA-based Biopharmaceuticals Forecast by Region (2023-2028)

12.1.2 Global RNA-based Biopharmaceuticals Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global RNA-based Biopharmaceuticals Forecast by Type

12.7 Global RNA-based Biopharmaceuticals Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer RNA-based Biopharmaceuticals Product Offered

13.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche RNA-based Biopharmaceuticals Product Offered

13.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 Sanofi-Aventis

13.3.1 Sanofi-Aventis Company Information

13.3.2 Sanofi-Aventis RNA-based Biopharmaceuticals Product Offered

13.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi-Aventis Main Business Overview

13.3.5 Sanofi-Aventis Latest Developments

13.4 Abbott Laboratories

13.4.1 Abbott Laboratories Company Information

13.4.2 Abbott Laboratories RNA-based Biopharmaceuticals Product Offered

13.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Abbott Laboratories Main Business Overview

13.4.5 Abbott Laboratories Latest Developments

13.5 Arrowhead Pharmaceuticals

13.5.1 Arrowhead Pharmaceuticals Company Information

13.5.2 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Offered

13.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Arrowhead Pharmaceuticals Main Business Overview

13.5.5 Arrowhead Pharmaceuticals Latest Developments

13.6 Benitec Biopharma

13.6.1 Benitec Biopharma Company Information

13.6.2 Benitec Biopharma RNA-based Biopharmaceuticals Product Offered

13.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Benitec Biopharma Main Business Overview

13.6.5 Benitec Biopharma Latest Developments

13.7 Calimmune Inc

13.7.1 Calimmune Inc Company Information

13.7.2 Calimmune Inc RNA-based Biopharmaceuticals Product Offered

13.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Calimmune Inc Main Business Overview

13.7.5 Calimmune Inc Latest Developments

13.8 Dicerna

13.8.1 Dicerna Company Information

13.8.2 Dicerna RNA-based Biopharmaceuticals Product Offered

13.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Dicerna Main Business Overview

13.8.5 Dicerna Latest Developments

13.9 Gradalis

13.9.1 Gradalis Company Information

13.9.2 Gradalis RNA-based Biopharmaceuticals Product Offered

13.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Gradalis Main Business Overview

13.9.5 Gradalis Latest Developments

13.10 Quark

13.10.1 Quark Company Information

13.10.2 Quark RNA-based Biopharmaceuticals Product Offered

13.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Quark Main Business Overview

13.10.5 Quark Latest Developments

13.11 RXi

13.11.1 RXi Company Information

13.11.2 RXi RNA-based Biopharmaceuticals Product Offered

13.11.3 RXi RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 RXi Main Business Overview

13.11.5 RXi Latest Developments

13.12 Senesco

13.12.1 Senesco Company Information

13.12.2 Senesco RNA-based Biopharmaceuticals Product Offered

13.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Senesco Main Business Overview

13.12.5 Senesco Latest Developments

13.13 Silence Therapeutics

13.13.1 Silence Therapeutics Company Information

13.13.2 Silence Therapeutics RNA-based Biopharmaceuticals Product Offered

13.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Silence Therapeutics Main Business Overview

13.13.5 Silence Therapeutics Latest Developments

13.14 Silenseed

13.14.1 Silenseed Company Information

13.14.2 Silenseed RNA-based Biopharmaceuticals Product Offered

13.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Silenseed Main Business Overview

13.14.5 Silenseed Latest Developments

13.15 Tekmira

13.15.1 Tekmira Company Information

13.15.2 Tekmira RNA-based Biopharmaceuticals Product Offered

13.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Tekmira Main Business Overview

13.15.5 Tekmira Latest Developments

13.16 Alnylam Pharmaceuticals

13.16.1 Alnylam Pharmaceuticals Company Information

13.16.2 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Offered

13.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Alnylam Pharmaceuticals Main Business Overview

13.16.5 Alnylam Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. RNA-based Biopharmaceuticals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. RNA-based Biopharmaceuticals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Therapeutics

Table 4. Major Players of Vaccines

Table 5. Global RNA-based Biopharmaceuticals Sales by Type (2017-2022) & (K Units)

Table 6. Global RNA-based Biopharmaceuticals Sales Market Share by Type (2017-2022)

Table 7. Global RNA-based Biopharmaceuticals Revenue by Type (2017-2022) & ($ million)

Table 8. Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2017-2022)

Table 9. Global RNA-based Biopharmaceuticals Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global RNA-based Biopharmaceuticals Sales by Application (2017-2022) & (K Units)

Table 11. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2017-2022)

Table 12. Global RNA-based Biopharmaceuticals Revenue by Application (2017-2022)

Table 13. Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2017-2022)

Table 14. Global RNA-based Biopharmaceuticals Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global RNA-based Biopharmaceuticals Sales by Company (2020-2022) & (K Units)

Table 16. Global RNA-based Biopharmaceuticals Sales Market Share by Company (2020-2022)

Table 17. Global RNA-based Biopharmaceuticals Revenue by Company (2020-2022) ($ Millions)

Table 18. Global RNA-based Biopharmaceuticals Revenue Market Share by Company (2020-2022)

Table 19. Global RNA-based Biopharmaceuticals Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers RNA-based Biopharmaceuticals Producing Area Distribution and Sales Area

Table 21. Players RNA-based Biopharmaceuticals Products Offered

Table 22. RNA-based Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global RNA-based Biopharmaceuticals Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global RNA-based Biopharmaceuticals Sales Market Share Geographic Region (2017-2022)

Table 27. Global RNA-based Biopharmaceuticals Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global RNA-based Biopharmaceuticals Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global RNA-based Biopharmaceuticals Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global RNA-based Biopharmaceuticals Sales Market Share by Country/Region (2017-2022)

Table 31. Global RNA-based Biopharmaceuticals Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global RNA-based Biopharmaceuticals Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas RNA-based Biopharmaceuticals Sales by Country (2017-2022) & (K Units)

Table 34. Americas RNA-based Biopharmaceuticals Sales Market Share by Country (2017-2022)

Table 35. Americas RNA-based Biopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas RNA-based Biopharmaceuticals Revenue Market Share by Country (2017-2022)

Table 37. Americas RNA-based Biopharmaceuticals Sales by Type (2017-2022) & (K Units)

Table 38. Americas RNA-based Biopharmaceuticals Sales Market Share by Type (2017-2022)

Table 39. Americas RNA-based Biopharmaceuticals Sales by Application (2017-2022) & (K Units)

Table 40. Americas RNA-based Biopharmaceuticals Sales Market Share by Application (2017-2022)

Table 41. APAC RNA-based Biopharmaceuticals Sales by Region (2017-2022) & (K Units)

Table 42. APAC RNA-based Biopharmaceuticals Sales Market Share by Region (2017-2022)

Table 43. APAC RNA-based Biopharmaceuticals Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC RNA-based Biopharmaceuticals Revenue Market Share by Region (2017-2022)

Table 45. APAC RNA-based Biopharmaceuticals Sales by Type (2017-2022) & (K Units)

Table 46. APAC RNA-based Biopharmaceuticals Sales Market Share by Type (2017-2022)

Table 47. APAC RNA-based Biopharmaceuticals Sales by Application (2017-2022) & (K Units)

Table 48. APAC RNA-based Biopharmaceuticals Sales Market Share by Application (2017-2022)

Table 49. Europe RNA-based Biopharmaceuticals Sales by Country (2017-2022) & (K Units)

Table 50. Europe RNA-based Biopharmaceuticals Sales Market Share by Country (2017-2022)

Table 51. Europe RNA-based Biopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe RNA-based Biopharmaceuticals Revenue Market Share by Country (2017-2022)

Table 53. Europe RNA-based Biopharmaceuticals Sales by Type (2017-2022) & (K Units)

Table 54. Europe RNA-based Biopharmaceuticals Sales Market Share by Type (2017-2022)

Table 55. Europe RNA-based Biopharmaceuticals Sales by Application (2017-2022) & (K Units)

Table 56. Europe RNA-based Biopharmaceuticals Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa RNA-based Biopharmaceuticals Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa RNA-based Biopharmaceuticals Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa RNA-based Biopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa RNA-based Biopharmaceuticals Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa RNA-based Biopharmaceuticals Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa RNA-based Biopharmaceuticals Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa RNA-based Biopharmaceuticals Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa RNA-based Biopharmaceuticals Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of RNA-based Biopharmaceuticals

Table 66. Key Market Challenges & Risks of RNA-based Biopharmaceuticals

Table 67. Key Industry Trends of RNA-based Biopharmaceuticals

Table 68. RNA-based Biopharmaceuticals Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. RNA-based Biopharmaceuticals Distributors List

Table 71. RNA-based Biopharmaceuticals Customer List

Table 72. Global RNA-based Biopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global RNA-based Biopharmaceuticals Sales Market Forecast by Region

Table 74. Global RNA-based Biopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas RNA-based Biopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas RNA-based Biopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC RNA-based Biopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC RNA-based Biopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe RNA-based Biopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe RNA-based Biopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa RNA-based Biopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa RNA-based Biopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global RNA-based Biopharmaceuticals Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Type (2023-2028)

Table 86. Global RNA-based Biopharmaceuticals Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global RNA-based Biopharmaceuticals Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Application (2023-2028)

Table 90. Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pfizer Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 93. Pfizer RNA-based Biopharmaceuticals Product Offered

Table 94. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Pfizer Main Business

Table 96. Pfizer Latest Developments

Table 97. Roche Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 98. Roche RNA-based Biopharmaceuticals Product Offered

Table 99. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Roche Main Business

Table 101. Roche Latest Developments

Table 102. Sanofi-Aventis Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi-Aventis RNA-based Biopharmaceuticals Product Offered

Table 104. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi-Aventis Main Business

Table 106. Sanofi-Aventis Latest Developments

Table 107. Abbott Laboratories Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 108. Abbott Laboratories RNA-based Biopharmaceuticals Product Offered

Table 109. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Abbott Laboratories Main Business

Table 111. Abbott Laboratories Latest Developments

Table 112. Arrowhead Pharmaceuticals Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 113. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Offered

Table 114. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Arrowhead Pharmaceuticals Main Business

Table 116. Arrowhead Pharmaceuticals Latest Developments

Table 117. Benitec Biopharma Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 118. Benitec Biopharma RNA-based Biopharmaceuticals Product Offered

Table 119. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Benitec Biopharma Main Business

Table 121. Benitec Biopharma Latest Developments

Table 122. Calimmune Inc Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 123. Calimmune Inc RNA-based Biopharmaceuticals Product Offered

Table 124. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Calimmune Inc Main Business

Table 126. Calimmune Inc Latest Developments

Table 127. Dicerna Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 128. Dicerna RNA-based Biopharmaceuticals Product Offered

Table 129. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Dicerna Main Business

Table 131. Dicerna Latest Developments

Table 132. Gradalis Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 133. Gradalis RNA-based Biopharmaceuticals Product Offered

Table 134. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Gradalis Main Business

Table 136. Gradalis Latest Developments

Table 137. Quark Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 138. Quark RNA-based Biopharmaceuticals Product Offered

Table 139. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Quark Main Business

Table 141. Quark Latest Developments

Table 142. RXi Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 143. RXi RNA-based Biopharmaceuticals Product Offered

Table 144. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. RXi Main Business

Table 146. RXi Latest Developments

Table 147. Senesco Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 148. Senesco RNA-based Biopharmaceuticals Product Offered

Table 149. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Senesco Main Business

Table 151. Senesco Latest Developments

Table 152. Silence Therapeutics Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 153. Silence Therapeutics RNA-based Biopharmaceuticals Product Offered

Table 154. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Silence Therapeutics Main Business

Table 156. Silence Therapeutics Latest Developments

Table 157. Silenseed Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 158. Silenseed RNA-based Biopharmaceuticals Product Offered

Table 159. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Silenseed Main Business

Table 161. Silenseed Latest Developments

Table 162. Tekmira Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 163. Tekmira RNA-based Biopharmaceuticals Product Offered

Table 164. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Tekmira Main Business

Table 166. Tekmira Latest Developments

Table 167. Alnylam Pharmaceuticals Basic Information, RNA-based Biopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 168. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Offered

Table 169. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Alnylam Pharmaceuticals Main Business

Table 171. Alnylam Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of RNA-based Biopharmaceuticals

Figure 2. RNA-based Biopharmaceuticals Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global RNA-based Biopharmaceuticals Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global RNA-based Biopharmaceuticals Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. RNA-based Biopharmaceuticals Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Therapeutics

Figure 10. Product Picture of Vaccines

Figure 11. Global RNA-based Biopharmaceuticals Sales Market Share by Type in 2021

Figure 12. Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2017-2022)

Figure 13. RNA-based Biopharmaceuticals Consumed in Cancer

Figure 14. Global RNA-based Biopharmaceuticals Market: Cancer (2017-2022) & (K Units)

Figure 15. RNA-based Biopharmaceuticals Consumed in Diabetes

Figure 16. Global RNA-based Biopharmaceuticals Market: Diabetes (2017-2022) & (K Units)

Figure 17. RNA-based Biopharmaceuticals Consumed in Tuberculosis

Figure 18. Global RNA-based Biopharmaceuticals Market: Tuberculosis (2017-2022) & (K Units)

Figure 19. RNA-based Biopharmaceuticals Consumed in Cardiovascular Diseases

Figure 20. Global RNA-based Biopharmaceuticals Market: Cardiovascular Diseases (2017-2022) & (K Units)

Figure 21. RNA-based Biopharmaceuticals Consumed in Others

Figure 22. Global RNA-based Biopharmaceuticals Market: Others (2017-2022) & (K Units)

Figure 23. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2017-2022)

Figure 24. Global RNA-based Biopharmaceuticals Revenue Market Share by Application in 2021

Figure 25. RNA-based Biopharmaceuticals Revenue Market by Company in 2021 ($ Million)

Figure 26. Global RNA-based Biopharmaceuticals Revenue Market Share by Company in 2021

Figure 27. Global RNA-based Biopharmaceuticals Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global RNA-based Biopharmaceuticals Revenue Market Share by Geographic Region in 2021

Figure 29. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2017-2022)

Figure 30. Global RNA-based Biopharmaceuticals Revenue Market Share by Country/Region in 2021

Figure 31. Americas RNA-based Biopharmaceuticals Sales 2017-2022 (K Units)

Figure 32. Americas RNA-based Biopharmaceuticals Revenue 2017-2022 ($ Millions)

Figure 33. APAC RNA-based Biopharmaceuticals Sales 2017-2022 (K Units)

Figure 34. APAC RNA-based Biopharmaceuticals Revenue 2017-2022 ($ Millions)

Figure 35. Europe RNA-based Biopharmaceuticals Sales 2017-2022 (K Units)

Figure 36. Europe RNA-based Biopharmaceuticals Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa RNA-based Biopharmaceuticals Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa RNA-based Biopharmaceuticals Revenue 2017-2022 ($ Millions)

Figure 39. Americas RNA-based Biopharmaceuticals Sales Market Share by Country in 2021

Figure 40. Americas RNA-based Biopharmaceuticals Revenue Market Share by Country in 2021

Figure 41. United States RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC RNA-based Biopharmaceuticals Sales Market Share by Region in 2021

Figure 46. APAC RNA-based Biopharmaceuticals Revenue Market Share by Regions in 2021

Figure 47. China RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 51. India RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe RNA-based Biopharmaceuticals Sales Market Share by Country in 2021

Figure 54. Europe RNA-based Biopharmaceuticals Revenue Market Share by Country in 2021

Figure 55. Germany RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 56. France RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa RNA-based Biopharmaceuticals Sales Market Share by Country in 2021

Figure 61. Middle East & Africa RNA-based Biopharmaceuticals Revenue Market Share by Country in 2021

Figure 62. Egypt RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country RNA-based Biopharmaceuticals Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of RNA-based Biopharmaceuticals in 2021

Figure 68. Manufacturing Process Analysis of RNA-based Biopharmaceuticals

Figure 69. Industry Chain Structure of RNA-based Biopharmaceuticals

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles